Location History:
- Umeå, SE (2005)
- Ume{dot over (a)}, SE (2008)
Company Filing History:
Years Active: 2005-2008
Title: Thore Johansson: Innovator in Nucleic Acid Research
Introduction
Thore Johansson is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of nucleic acid research, particularly in the study of GABAB receptor 1 promoters. With a total of 2 patents to his name, Johansson's work has implications for understanding transcription modulation.
Latest Patents
Johansson's latest patents focus on nucleic acid molecules that constitute GABAB receptor 1 promoters P1a and/or P1b. These inventions include methods for screening compounds that act as modulators of GABAB receptor 1 transcription. The patents emphasize the use of these nucleic acid molecules in research and potential therapeutic applications.
Career Highlights
Thore Johansson is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to explore innovative solutions in the realm of genetic research and drug development.
Collaborations
Johansson has collaborated with notable colleagues such as Anders Edlund and Jonas Ekstrand. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.
Conclusion
Thore Johansson's contributions to nucleic acid research and his innovative patents highlight his role as a key figure in the scientific community. His work continues to influence the understanding of GABAB receptor modulation and its potential applications in medicine.